Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sigachi Industries invests USD 1 million in R&D centre to boost API development
New facility in Hyderabad to optimise API synthesis and regulatory compliance
IXP launches Lifesciences catalyst fund for early-stage investments
Fund targets INR 200 crore corpus with focus on biotech, pharma, and medical
Syngene International appoints Peter Bains as CEO Designate
Jonathan Hunt steps down as MD & CEO; Board announces leadership transition
Government mandates drug price list display for all pharmacies
Online and offline pharmacies must comply with the Drugs (Prices Control) Order, 2013
Pfizer and Astellas announce extended survival data from EV-302 trial in advanced urothelial cancer
Additional follow-up from the Phase 3 study shows sustained overall survival benefit of enfortumab vedotin and pembrolizumab…
Lupin receives U.S. FDA approval for generic Ipratropium Bromide nasal spray
Approval allows marketing of generic equivalent of Atrovent Nasal Spray in the U.S.
Glenmark secures MHRA approval to launch Winlevi in the UK
Winlevi, licensed from Cosmo Pharmaceuticals, introduces a new topical approach to acne treatment
Venus Remedies secures marketing authorisation for Enoxaparin in Indonesia
Approval expands company’s footprint in Southeast Asia’s growing anticoagulant market
India is rising from a CDMO perspective when it comes to biologics
Bill Coyle, principal, ZS, discusses India's growing role in biologics from a CDMO perspective and how AI is shaping pharma.…
Biovet receives CDSCO licence DIVA marker vaccine for lumpy skin disease
BIOLUMPIVAXIN, developed with ICAR, is reportedly India’s first LSD vaccine